drugset / Trial / NCT01604057
Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being conducted to evaluate the effect treatment has on serum P1NP levels, a biomarker of bone formation in postmenopausal women with low bone mass.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TERIPARATIDE | Protein / enzyme biologic | — | Intranasal |
| Comparator | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |